Publication: ERF deletion rescues RAS deficiency in mouse embryonic stem cells
Loading...
Identifiers
Publication date
2018-04-01
Authors
Mayor-Ruiz, Cristina CNIO
Olbrich, Teresa
Drosten, Matthias CNIO 
Lecona, Emilio
Vega-Sendino, Maria
Dominguez, Orlando CNIO
Barbacid, Mariano CNIO
Ruiz, Sergio
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Cold Spring Harbor Laboratory Press
Metrics
Export
Abstract
MEK inhibition in combination with a glycogen synthase kinase-3β (GSK3β) inhibitor, referred as the 2i condition, favors pluripotency in embryonic stem cells (ESCs). However, the mechanisms by which the 2i condition limits ESC differentiation and whether RAS proteins are involved in this phenomenon remain poorly understood. Here we show that RAS nullyzygosity reduces the growth of mouse ESCs (mESCs) and prohibits their differentiation. Upon RAS deficiency or MEK inhibition, ERF (E twenty-six 2 [Ets2]-repressive factor), a transcriptional repressor from the ETS domain family, translocates to the nucleus, where it binds to the enhancers of pluripotency factors and key RAS targets. Remarkably, deletion of Erf rescues the proliferative defects of RAS-devoid mESCs and restores their capacity to differentiate. Furthermore, we show that Erf loss enables the development of RAS nullyzygous teratomas. In summary, this work reveals an essential role for RAS proteins in pluripotency and identifies ERF as a key mediator of the response to RAS/MEK/ERK inhibition in mESCs.
Description
Keywords
DeCS Terms
Bibliographic citation
Genes Dev. 2018;32(7-8):568-576